Silber S J, Nagy Z, Devroey P, Tournaye H, Van Steirteghem A C
Infertility Center of St Louis, St Luke's Hospital, Missouri 63017, USA.
Hum Reprod. 1997 Nov;12(11):2422-8. doi: 10.1093/humrep/12.11.2422.
The aim of the study was to determine whether a prior diagnostic testicle biopsy can predict success or failure of testicular sperm extraction (TESE) with intracytoplasmic sperm injection (ICSI) in patients with non-obstructive azoospermia caused by testicular failure, and what is the minimum threshold of sperm production in the testis which must be surpassed for spermatozoa to reach the ejaculate. Forty-five patients with non-obstructive azoospermia caused by testicular failure underwent diagnostic testicle biopsy prior to a planned future TESE-ICSI procedure. The diagnostic testicle biopsy was analysed quantitatively, and correlated with the quantitative findings of spermatogenesis in patients with normal spermatogenesis, as well as with the results of subsequent attempts at TESE-ICSI. Men with non-obstructive azoospermia caused by germinal failure had a mean of 0-6 mature spermatids/seminiferous tubule seen on a diagnostic testicle biopsy, compared to 17-35 mature spermatids/tubule in men with normal spermatogenesis and obstructive azoospermia. These findings were the same for all types of testicular failure whether Sertoli cell only, maturation arrest, cryptorchidism, or post-chemotherapy azoospermia. Twenty-two of 26 men with mature spermatids found in the prior testis biopsy had successful retrieval of spermatozoa for ICSI, 12 of their partners became pregnant, and are either ongoing or delivered. The study suggests that 4-6 mature spermatids/tubule must be present in the testis biopsy for any spermatozoa to reach the ejaculate. More than half of azoospermic patients with germinal failure have minute foci of spermatogenesis which are insufficient to produce spermatozoa in the ejaculate. Prior diagnostic testicle biopsy analysed quantitatively (for the presence of mature spermatids) can predict subsequent success or failure with TESE-ICSI. Incomplete testicular failure may involve a sparse multi-focal distribution of spermatogenesis throughout the entire testicle, rather than a regional distribution. Therefore, it is possible that massive testicular sampling from many different regions of the testes may not be necessary for successful TESE-ICSI.
本研究的目的是确定在因睾丸功能衰竭导致非梗阻性无精子症的患者中,先前的诊断性睾丸活检能否预测睾丸精子提取(TESE)联合卵胞浆内单精子注射(ICSI)的成功或失败,以及睾丸中精子产生的最低阈值必须超过多少精子才能进入精液。45例因睾丸功能衰竭导致非梗阻性无精子症的患者在计划进行未来的TESE-ICSI手术前接受了诊断性睾丸活检。对诊断性睾丸活检进行了定量分析,并与精子发生正常的患者的精子发生定量结果以及随后的TESE-ICSI尝试结果进行了关联。与生精正常和梗阻性无精子症的男性相比,因生精功能衰竭导致非梗阻性无精子症的男性在诊断性睾丸活检中平均每生精小管可见0-6个成熟精子细胞,而生精正常和梗阻性无精子症的男性为17-35个成熟精子细胞/小管。无论睾丸功能衰竭的类型是唯支持细胞综合征、成熟停滞、隐睾症还是化疗后无精子症,这些发现都是相同的。在先前睾丸活检中发现有成熟精子细胞的26名男性中,有22名成功获取了用于ICSI的精子,他们的12名伴侣怀孕,且妊娠仍在继续或已分娩。该研究表明,睾丸活检中必须存在4-6个成熟精子细胞/小管,才会有任何精子进入精液。超过一半的生精功能衰竭的无精子症患者有微小的生精灶,不足以在精液中产生精子。对先前的诊断性睾丸活检进行定量分析(以确定成熟精子细胞的存在)可以预测随后TESE-ICSI的成功或失败。不完全睾丸功能衰竭可能涉及整个睾丸中生精的稀疏多灶性分布,而不是区域性分布。因此,对于成功的TESE-ICSI,可能没有必要从睾丸的许多不同区域进行大量睾丸取样。